Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Clinical trial update on shockwave therapy and future of erectile function restoration

Abstract

Our interim analysis of a phase II clinical trial on low-intensity extracorporeal shockwave therapy (Li-ESWT) for men with erectile dysfunction (ED) has demonstrated it is safe with no reported adverse outcomes. Interim analysis has demonstrated Sexual Encounter Profile 3 (ability to maintain erection till completion) was achieved in 60% of men prior to Li-ESWT, which increased to 90% after treatment. Nevertheless, limitations of our clinical trial include the lack of a sham arm and our inability to exclude men with psychogenic ED. We have begun recruitment of our phase III clinical trial that will allow assessment of treatment efficacy against a sham control arm. There exists substantial interest in the use of restorative therapies (i.e., Li-ESWT, stem cells, and platelet rich plasma) for men with ED with the potential to combine therapies to potentially lead to an augmented response.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

References

  1. Rizk PJ, Krieger JR, Kohn TP, Pastuszak AW. Low-intensity shockwave therapy for erectile dysfunction. Sex Med Rev. 2018;6:624–30.

    Article  Google Scholar 

  2. Young Academic Urologists Men’s Health Group, Fode M, Hatzichristodoulou H, Serefoglu EC, Verze P, Albersen M. Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough? Nat Rev Urol. 2017;14:595–606.

    Google Scholar 

  3. Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. Eur Urol. 2010;58:243–8.

    Article  Google Scholar 

  4. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200:633–41.

    Article  Google Scholar 

  5. SMSNA Position Statement On Restorative Therapies for ED. Accessed 10 December 2018. http://www.smsna.org/V1/news/433-smsna-position-statement-on-restorative-therapies-for-ed.

  6. Wang J, Zhou C, Liu L, Pan X, Guo T. Clinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: a systematic review and meta-analysis. Eur J Clin Invest. 2015;45:1270–85.

    Article  CAS  Google Scholar 

  7. Zhang H, Li ZL, Yang F, Zhang Q, Su XZ, Li J et al. Radial shockwave treatment promotes human mesenchymal stem cell self-renewal and enhances cartilage healing. Stem Cell Res Ther. 2018; e-pub ahead of print 9 March 2018; https://doi.org/10.1186/s13287-018-0805-5.

  8. Zhu GQ, Jeon SH, Bae WJ, Choi SW, Jeong HC, Kim SJ et al. Efficient Promotion of Autophagy and Angiogenesis Using Mesenchymal Stem Cell Therapy Enhanced by the Low-Energy Shock Waves in the Treatment of Erectile Dysfunction. Stem Cells Int. 2018; e-pub ahead of print 29 August 2018; https://doi.org/10.1155/2018/1302672.

    Google Scholar 

  9. Li J, Matheu MP, Sun F, Wang L, Sanford MT, Ning H, et al. Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model. J Sex Med. 2016;13:22–32.

    Article  Google Scholar 

  10. Katz JE, Molina ML, Clavijo R, Prakesh NS, Ramasamy R. A phase 2 randomized trial to evaluate different dose regimens of low-intensity extracorporeal shockwave therapy for erectile dysfunction: clinical trial update. Eur Urol Focus. 2018;4:336–7.

    Article  Google Scholar 

  11. Raabe O, Shell K, Joessi A, Crispens C, Delhasse Y, Eva A, et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells. 2013;2:62–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Yin TC, Wu RW, Sheu JJ, Sung PH, Chen KH, Chiang JY et al. Reperfusion Injury of Quadriceps Muscle. Oxid Med Cell Longev. 2018; e-pub ahead of print 2 April 2018; https://doi.org/10.1155/2018/6012636.

    Article  Google Scholar 

Download references

Funding

Barton Weiss Men’s Health Initiative

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ranjith Ramasamy.

Ethics declarations

Conflict of interest

RR is the Principal Investigator for the Phase II & III Shockwave Clinical Trial. Remaining authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, P., Huang, C., Molina, M. et al. Clinical trial update on shockwave therapy and future of erectile function restoration. Int J Impot Res 31, 206–208 (2019). https://doi.org/10.1038/s41443-019-0115-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41443-019-0115-1

This article is cited by

Search

Quick links